These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 7901318

  • 1. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance.
    Boussiotis VA, Freeman GJ, Gray G, Gribben J, Nadler LM.
    J Exp Med; 1993 Nov 01; 178(5):1753-63. PubMed ID: 7901318
    [Abstract] [Full Text] [Related]

  • 2. CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy.
    Boussiotis VA, Freeman GJ, Griffin JD, Gray GS, Gribben JG, Nadler LM.
    J Exp Med; 1994 Nov 01; 180(5):1665-73. PubMed ID: 7525835
    [Abstract] [Full Text] [Related]

  • 3. R24 anti-GD3 ganglioside antibody can induce costimulation and prevent the induction of alloantigen-specific T cell clonal anergy.
    Boussiotis VA, Pardo NA, Collins H, Houghton A, Ritz J, Nadler LM, Soiffer RJ.
    Eur J Immunol; 1996 Sep 01; 26(9):2149-54. PubMed ID: 8814260
    [Abstract] [Full Text] [Related]

  • 4. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.
    Gimmi CD, Freeman GJ, Gribben JG, Gray G, Nadler LM.
    Proc Natl Acad Sci U S A; 1993 Jul 15; 90(14):6586-90. PubMed ID: 7688125
    [Abstract] [Full Text] [Related]

  • 5. A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.
    Behar SM, Porcelli SA, Beckman EM, Brenner MB.
    J Exp Med; 1995 Dec 01; 182(6):2007-18. PubMed ID: 7500046
    [Abstract] [Full Text] [Related]

  • 6. Intercellular adhesion molecule 1 is critical for activation of CD28-deficient T cells.
    Gaglia JL, Greenfield EA, Mattoo A, Sharpe AH, Freeman GJ, Kuchroo VK.
    J Immunol; 2000 Dec 01; 165(11):6091-8. PubMed ID: 11086041
    [Abstract] [Full Text] [Related]

  • 7. Alloantigen-specific T-cell anergy induced by human keratinocytes is abrogated upon loss of cell-cell contact.
    Otten HG, Bor B, Ververs C, Verdonck LF, De Boer M, De Gast GC.
    Immunology; 1996 Jun 01; 88(2):214-9. PubMed ID: 8690453
    [Abstract] [Full Text] [Related]

  • 8. Induction of alloantigen-specific T cell tolerance through the treatment of human T lymphocytes with wortmannin.
    Taub DD, Murphy WJ, Asai O, Fenton RG, Peltz G, Key ML, Turcovski-Corrales S, Longo DL.
    J Immunol; 1997 Mar 15; 158(6):2745-55. PubMed ID: 9058809
    [Abstract] [Full Text] [Related]

  • 9. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes.
    Damle NK, Klussman K, Linsley PS, Aruffo A.
    J Immunol; 1992 Apr 01; 148(7):1985-92. PubMed ID: 1372018
    [Abstract] [Full Text] [Related]

  • 10. Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen.
    Cardoso AA, Schultze JL, Boussiotis VA, Freeman GJ, Seamon MJ, Laszlo S, Billet A, Sallan SE, Gribben JG, Nadler LM.
    Blood; 1996 Jul 01; 88(1):41-8. PubMed ID: 8704200
    [Abstract] [Full Text] [Related]

  • 11. Intercellular adhesion molecule-1/leukocyte function associated antigen-1 blockade inhibits alloantigen specific human T cell effector functions without inducing anergy.
    Calhoun RF, Oppat WF, Duffy B, Mohanakumar T.
    Transplantation; 1999 Oct 27; 68(8):1144-52. PubMed ID: 10551644
    [Abstract] [Full Text] [Related]

  • 12. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
    van Seventer GA, Newman W, Shimizu Y, Nutman TB, Tanaka Y, Horgan KJ, Gopal TV, Ennis E, O'Sullivan D, Grey H.
    J Exp Med; 1991 Oct 01; 174(4):901-13. PubMed ID: 1717633
    [Abstract] [Full Text] [Related]

  • 13. Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro.
    Comoli P, Montagna D, Moretta A, Zecca M, Locatelli F, Maccario R.
    J Immunol; 1995 Dec 15; 155(12):5506-11. PubMed ID: 7499831
    [Abstract] [Full Text] [Related]

  • 14. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.
    Tan P, Anasetti C, Hansen JA, Melrose J, Brunvand M, Bradshaw J, Ledbetter JA, Linsley PS.
    J Exp Med; 1993 Jan 01; 177(1):165-73. PubMed ID: 7678111
    [Abstract] [Full Text] [Related]

  • 15. Activated B cells express CD28/B7-independent costimulatory activity.
    Ding L, Shevach EM.
    J Immunol; 1996 Aug 15; 157(4):1389-96. PubMed ID: 8759718
    [Abstract] [Full Text] [Related]

  • 16. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
    Fenton RG, Turcovski-Corrales SM, Taub DD.
    J Immunother; 1998 Mar 15; 21(2):95-108. PubMed ID: 9551360
    [Abstract] [Full Text] [Related]

  • 17. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response.
    Dubey C, Croft M, Swain SL.
    J Immunol; 1995 Jul 01; 155(1):45-57. PubMed ID: 7541426
    [Abstract] [Full Text] [Related]

  • 18. Costimulation with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 augments activation-induced death of antigen-specific CD4+ T lymphocytes.
    Damle NK, Klussman K, Leytze G, Aruffo A, Linsley PS, Ledbetter JA.
    J Immunol; 1993 Sep 01; 151(5):2368-79. PubMed ID: 7689606
    [Abstract] [Full Text] [Related]

  • 19. T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.
    Wingren AG, Parra E, Varga M, Kalland T, Sjogren HO, Hedlund G, Dohlsten M.
    Crit Rev Immunol; 2017 Sep 01; 37(2-6):463-481. PubMed ID: 29773030
    [Abstract] [Full Text] [Related]

  • 20. Alloantigenic stimulation bypasses CD28-B7 costimulatory blockade by an interleukin-2-dependent mechanism.
    Blazevic V, Pinto LA, Trubey CM, Shearer GM.
    J Leukoc Biol; 2000 Jun 01; 67(6):817-24. PubMed ID: 10857854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.